Abstract: . . .  00-3029; originally printed 1990; revised July 2000. 19. Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 2001; 357: 209-15. 20. Magee LA, Ornstein MP, von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ 1999; 318: 1332-6. 21. The Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sul- phate? The Magpie Trial: a randomised placebo-controlled trial. Lancet . . .
. . .  severity. Serum creatinine Levels drop in pregnancy. Elevated levels suggest increasing severity of hypertension ; assessment of 24-h creatinine clearance may be necessary. 2004; 5: No. 2r HYPERTENSION IN PREGNANCY: RECOMMENDATIONS FOR DIAGNOSIS AND TREATMENT Renata Cfkov, Institute for Clinical and Experimental Medicine, Prague, Czech Republic Page 2 Non-pharmacological management and prevention . . .
. . .  creatinine Levels drop in pregnancy. Elevated levels suggest increasing severity of hypertension ; assessment of 24-h creatinine clearance may be necessary. 2004; 5: No. 2r HYPERTENSION IN PREGNANCY: RECOMMENDATIONS FOR DIAGNOSIS AND TREATMENT Renata Cfkov, Institute for Clinical and Experimental Medicine, Prague, Czech Republic Page 2 Non-pharmacological management and prevention of hyper-  . . .
. . .  Pregnancy. NIH Publication No. 00-3029; originally printed 1990; revised July 2000. 19. Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 2001; 357: 209-15. 20. Magee LA, Ornstein MP, von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ 1999; 318: 1332-6. 21. The Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sul- phate? The Magpie Trial: a randomised . . .
. . .  tension in pregnancy Non-pharmacological management should be considered for pregnant women with SPB of 140-150 mm Hg or DBP of 90-99 mmHg or both, measured in a clinical setting. A short-term hospi- tal stay may be required for diagnosis and for ruling out severe gestational hypertension (pre-eclampsia), in which the only effec- tive treatment is delivery. Management, depending on BP, gesta- tional age and presence of associated maternal and fetal risk fac- . . .
. . .  P. Fortnightly review: management of hypertension in pregnancy. BMJ 1999; 318: 1332-6. 21. The Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sul- phate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002; 359: 1877-90.  . . .
--3000,6,250,3258,17317